Takeda Hid Actos Bladder Cancer Risks, Whistleblower Case Says

Takeda Hid Actos Bladder Cancer Risks, Whistleblower Case Says

The U.S. District Judge F. Dennis Saylor issued an order to unseal a whistleblower case by a former Takeda Pharmaceuticals medical reviewer involving the failure to report bladder cancer and…

More in Health >
Avandia panel says diabetes drug should stay on market

Avandia panel says diabetes drug should stay on market

Shocker from the FDA advisory panel: it voted Avandia should stay on the market despite the fact it increases the risk for heart attack. Total vote count: 20 for continued…

More in News >
Avandia studies place medication on edge of recall

Avandia studies place medication on edge of recall

Heart Risk from Popular Diabetes Medication The diabetes medication Avandia by GlaxoSmithKline has been the subject of two studies that were released Monday. These studies show that the use of…

More in Health >
Will Diabetes Drug Avandia Be Recalled?

Will Diabetes Drug Avandia Be Recalled?

The diabetes drug Avandia seems to be on the high wire. According to the Wall Street Journal the FDA is planning to shut down a study between the side effects…

More in Health >
GlaxoSmithKline Pushed Diabetes Drug Avandia Despite Heart Attack Risks

GlaxoSmithKline Pushed Diabetes Drug Avandia Despite Heart Attack Risks

One of the key risks for people with diabetes is heart attacks. The diabetes medication Avandia is known to cause heart attacks, which doubles the risks for diabetic patients. Insurance…

More in Health >